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In eukaryotes, messenger RNA biogenesis depends on the ordered and precise assembly of a nuclear messenger ribonucleoprotein
particle (mRNP) during transcription. This process requires a well-orchestrated and dynamic sequence of molecular recognition
events by speciﬁc RNA-binding proteins. Arginine methylation is a posttranslational modiﬁcation found in a plethora of RNA-
binding proteins responsible for mRNP biogenesis. These RNA-binding proteins include both heterogeneous nuclear ribonucleo-
proteins (hnRNPs) and serine/arginine-rich (SR) proteins. In this paper, I discuss the mechanisms of action by which arginine
methylation modulates various facets of mRNP biogenesis, and how the collective consequences of this modiﬁcation impart the
speciﬁcity required to generate a mature, translational- and export-competent mRNP.
1.Introduction
In eukaryotic cells, transcription is central to control of
the level of gene expression, which, in turn, is critical for
normal cell growth, development, and cellular diﬀerenti-
ation. During eukaryotic transcription, the nascent pre-
mRNA associates with a myriad of RNA-binding proteins,
allowing a series of RNA processing steps to take place
in a transcription-dependent manner (reviewed in [1, 2]).
These processing steps include 5 -end capping, splicing, 3 -
end cleavage, and polyadenylation. Many factors involved
in these steps physically and functionally associate with the
carboxy-terminal domain (CTD) of RNA polymerase II (pol
II) (reviewed in [3, 4]). A number of extensively studied
RNA-binding proteins function in pre-mRNA splicing and
the intracellular transport of mature and stable mRNAs.
These include members of both the serine/arginine-rich
(SR)proteins and heterogeneous nuclear ribonucleoproteins
(hnRNP) families (reviewed in [5, 6]). Once transcription
is complete, the mature message is coated with a unique
complement of RNA-binding proteins, forming a messenger
ribonucleoprotein particle (mRNP) that is then exported
out of the nucleus for translation of the RNA component
in the cytoplasm. mRNPs in the process of assembly are
checked for export competence by nuclear surveillance
mechanisms, and any aberrant mRNP is subject to control
by such a mechanism. One example of such a mechanism
is the nonsense-mediated decay (NMD) pathway, which
retains defective mRNPs to be degraded, thereby preventing
them from being translated (reviewed in [7, 8]). Given
the coupling between particular steps of transcription and
speciﬁc RNA processing events, mRNP biogenesis must be
carried out in a dynamic and coordinated manner, and this
is accomplished by a series of molecular recognition events
during transcription.
Protein arginine methylation is a type of post-trans-
lational modiﬁcation that has been identiﬁed in many
of the factors that are involved in the production of a
mature, translatable mRNP, and has emerged as a major
regulator of protein function in mRNP dynamics. This
particular modiﬁcation is catalyzed by members of an
enzyme family known as protein arginine methyltransferases
(PRMTs) (reviewed in [9, 10]). To date, ten mammalian
PRMTshavebeenidentiﬁedbasedontheirprimary sequence
and substrate speciﬁcity, with six displaying type I activity
(PRMT1, PRMT2, PRMT3, PRMT4, PRMT6, and PRMT8)
and two displaying type II activity (PRMT5, PRMT7).
PRMT7 has also been shown to display type III activity.
All of the identiﬁed PRMTs use S-adenosyl-L-methionine
(AdoMet) as the methyl donor in the methyltransferase
reaction. The type I PRMTs transfer either one or two
methyl groups from AdoMet to a single guanidino nitrogen
on a protein-incorporated arginine residue, thus forming
either a monomethylarginine (MMA) or an asymmetric2 Molecular Biology International
dimethylarginine (aDMA). Type II PRMTs also catalyze
monomethylation; however, they then proceed to add the
second methyl group to the opposing guanidino nitrogen
within the arginine residue, thereby forming a symmetric
dimethylarginines (sDMA). Among eukaryotes, PRMT1 is
the most highly conserved type I PRMT, and PRMT5 is
the most highly conserved type II PRMT. Homologs of
mammalian PRMTs can be found in trypanosomes, one of
the earliest diverged eukaryotes. The preferred methylation
target sequence for PRMT1 is an arginine residue ﬂanked by
one or more glycine residues (e.g., RGG) [11, 12], although
ﬁndings from in vitro substrate proﬁling suggest that this
enzyme may have additional target sequences [13]. Many
of the RNA processing factors involved in mRNP biogenesis
contain “RGG” boxes, domains known to participate in both
protein-protein and protein-RNA interactions (reviewed in
[14]). The aDMA-generatingenzymes PRMT3, PRMT6, and
PRMT8 also mostly methylate GAR (glycine and arginine-
rich) motifs; to date, PRMT4 (also known as CARM1) has
no known preferred motif. The sDMA-generating enzyme
PRMT5 methylates arginines that are either next to or within
GAR motifs. These general rules regarding methylation
sites are subject to many exceptions, and the identiﬁcation
of additional PRMT substrates may warrant a revision of
these notions in the future. The compendium of RNA
processing factors that contain mono- and dimethylated
arginines, as established by analysis using both arginine
dimethyl-speciﬁc antibodies and proteomic identiﬁcation
technologies, is substantial [15, 16]. However, in many cases,
it remains to be determined how these methylated arginines
inﬂuence the molecular activities of many of the aﬀected
RNA-binding proteins. In this review, I will discuss our





mRNAs (reviewed in [17]). The macromolecular machinery
that carries outpre-mRNA splicing is called the spliceosome,
a complex comprised of ﬁve U small nuclear ribonucleopro-
tein particles (snRNPs) and a large number of non-snRNP
proteins (reviewed in [18, 19]). In mammalian cells, each
spliceosomal snRNP is ﬁrst assembled in the cytoplasm from
a seven-membered ring of core Sm proteins (SmB/B’, SmD1,
SmD2, SmD3, SmE, SmF, and SmG) and a newly exported
snRNA (U1, U2, U4, or U5). The mature snRNPs in the
cytoplasm are then imported into the nucleus, where they
function in pre-mRNA splicing (reviewed in [20]). A prop-
erly assembled Sm core is required for the nuclear import
of mature cytoplasmic U-snRNPs. Once in the nucleus,
the U-snRNPs are further processed in Cajal bodies before
becoming incorporated into a functional spliceosome, and it
is the U-snRNP that enables the spliceosome to carry out the
catalytic step in pre-mRNA splicing (reviewed in [21]).
Theinitialcluethatsuggestedaroleforargininemethyla-
tion in U-snRNP function was the ﬁnding of sDMAs on the
C-terminal RG dipeptide repeats of the Sm proteins SmD1
and SmD3 [22]. The survival of motor neurons (SMN)
protein, which is required for the cytoplasmic assembly of
U-snRNPs (reviewed in [23, 24]), preferentially binds to
dimethylarginine-modiﬁed RGdomains ofSmD1andSmD3
[25], demonstrating that this modiﬁcation is functionally
signiﬁcant in U-snRNP biogenesis. The Luhrmann group
further showed that SmB/B’ and Sm-like protein LSm4
also contain sDMAs, and that symmetric dimethylation of
the four Sm/Sm-Like proteins (SmD1, SmD3, SmB/B’, and
LSm4) facilitates their interaction with the SMN protein
[26]. The interaction between the Sm proteins and SMN
requires SMN’s Tudor domain, a structural motif that
consists of approximately 60 amino acids [27] and is now
recognized as a methyl-amino-acid-binding protein module
[28, 29]. Using an sDMA-speciﬁc antibody, the Richard
group immunoprecipitated coilin and the Sm proteins Sm
B/B’ and SmD [30]. In addition, they showed that arginine
methylation is required for the localization of SMN to Cajal
bodies [30].
PRMT5 has been linked to the methylation of Sm
proteins by studies showing that a protein complex called
themethylosome, whichincorporatesPRMT5alongwithSm
proteins and pICln, catalyzes sDMA formation on the Sm
proteins [31, 32]. PRMT5 may accomplish this by binding
to the RG domains of SmD1and SmD3[31]. pIClnis known
to bind to the Smdomain of Sm proteins, and negatively reg-
ulates snRNP assembly [32, 33]. Reconstitution experiments
invitroshowedthatPRMT5promotes,inanATP-dependent
manner, the direct transfer of Sm proteins by the SMN
complex onto the U-snRNAs [34], consistent with the ﬁnd-
ing that small interfering RNA-(siRNA-) mediated PRMT5
knockdown correlates with decreased recognition of SmB/B’
and SmD epitopes by the sDMA-speciﬁc antibody [30].
Together, these data demonstrate that PRMT5 is the
enzyme that methylates the Sm proteins, and that methyla-
tion provides the signal needed for Sm proteins to target the
SMNcomplexfortheassemblyofsnRNPcoreparticle.Given
that proper, functional pre-mRNA splicing requires mature
U-snRNPs, it would not be surprising to ﬁnd that defects
leading to incorrectly assembled U-snRNP compromise the
splicing ofpre-mRNAs. Indeed,depletionofsDMA-contain-
ing proteins from mammalian nuclear extracts by an sDMA-
speciﬁc antibody impairs pre-mRNA splicing and formation
of the spliceosomal complex [30]. In Arabidopsis, loss of the
PRMT5 homolog AtPRMT5 leads to widespread defects in
pre-mRNA splicing [35]. In Drosophila, the PRMT5-hom-
olog Dart5 plays a role in regulating alternative splicing of
speciﬁc target mRNAs [36].
Recent evidence has pointed to the involvement of ad-
ditional PRMTs in the biogenesis of Sm proteins. A study
by the Matera group showed that human PRMT7 is capable
of catalyzing sDMA formation in Sm proteins, indepen-
dent of PRMT5 activity [37]. This mechanism may be
functionally conserved in Drosophila,a sb o t hi t sP R M T 5
and PRMT7 homologs (Dart5 and Dart7, resp.) are
required for catalyzing sDMA formation on the Sm proteins
[38]. However, whereas Dart5-mediated methylation of Sm
proteins is required for an eﬃcient interaction betweenMolecular Biology International 3
Sm and SMN, the modiﬁcation is not required for snRNP
biogenesis, as it is in mammalian cells [37]. Rather, Dart5-
mediated methylation of Sm proteins is essential for germ-
cell speciﬁcation and maintenance [39]. It is possible that
the underlying cause of this diﬀerence in the requirement
for PRMT5-mediated methylation of Sm proteins in the
assembly of snRNPs is diﬀerences in the mechanism of
snRNP assembly in the two systems. Further complicating
our understanding of the role of arginine methylation is the
fact that whereas aDMA is present on SmD1, SmD3, and
SmB/B’proteinspuriﬁedfrommammaliannuclearfractions,
it is sDMA that is present on the same proteins puriﬁed
fromthecytoplasm[40].While thefunctional signiﬁcance of
aDMA on these Sm proteins remains to be determined, this
observation suggests that an additional aDMA-catalyzing
PRMT, possibly PRMT4/CARM1 [41, 42], is present in the
snRNP maturation pathway.
3.Arginine Methylationof hnRNPs
As RNA Pol II transcription commences, many hnRNPs are
recruitedto thenascent transcript forthe purpose ofregulat-
ing the life cycle of the mRNA (reviewed in [5]). The hnRNP
proteins vary vastly in terms of domain composition and
functional properties, with some promoting mRNPbiogene-
sis by eﬀecting pre-mRNA splicing and others the packaging
of mRNPs for nuclear export. The general characteristics
of some hnRNPs include RNA-binding domains, RGG
boxes with interspersed aromatic amino acids and auxiliary
domains such as GAR domains. While the bulk of hnRNP
proteinslocalize predominately tothe nucleusat steady state,
they undergo some nucleocytoplasmic shuttling, movement
that is thought to aid in the transport of mRNAs out of the
nucleus, as well as to serve certain cytoplasmic functions.
Early studies of partially puriﬁed hnRNP core complexes
in mammalian cells revealed the presence of dimethylargi-
nines in hnRNP A and B of this complex [43, 44]. Using
both in vitro and in vivo methylation assays, the Dreyfuss
group showed that many hnRNPs are arginine methylated,
including hnRNPs E, G, H, J, K, P, Q, R, and U [45]. Many
of these hnRNPs were subsequently conﬁrmed to contain
mono- and dimethylated arginines, using a proteomic meth-
od called SILAC (Staple Isotope Labeling by Amino acids
in Cell culture) [16] .T h i ss t u d yb yt h eM a n ng r o u p
also identiﬁed the same modiﬁcation in additional RNA-
binding proteins, and in hnRNPs that were previously not
known to be methylated [16]. PRMT1 is the PRMT that
catalyzes this modiﬁcation in many hnRNPs [46–48], but
others have been implicated [49]. The association of PRMT1
with hnRNP particles may be mediated through one of its
substrates, hnRNP U [50], a multifunctional nucleic-acid-
binding protein that is also known as scaﬀold attachment
factor A (SAF-A)and to have roles in transcription and RNA
maturation [51, 52]. However, it is not clear how arginine
methylation aﬀects the function of hnRNP U.
One of the functional consequences of arginine methyla-
tion for many hnRNPs is their relocalization within the cell.
In mammalian cells, arginine methylation facilitates nuclear
import or slowing of nuclear export of these hnRNPs. This
role is supported by the observation that the suppression,
in the cases of hnRNP A2 and Q, of arginine methylation
leads to a shift from predominately nuclear localization to
predominately cytoplasmic localization [46, 47, 53].
Treatment with the methyltransferase inhibitor adeno-
sine dialdehyde (AdOx) resulted in increased cytoplas-
mic localization of Src substrate-associated during mitosis
(Sam68), an RNA-binding protein that belongs to the
hnRNP K homology (KH) domain family [54]. In contrast
with observation from mammalian systems, arginine methy-
lation of the budding yeast S. cerevisiae hnRNP-like proteins
Npl3, Hrp1, and Nab2 promotes their proper nuclear export
[55, 56]. Npl3 is a major yeast mRNA export factor and pos-
sesses characteristics of both hnRNP and SR-family proteins
[57–59]. In yeast cells carrying a speciﬁc mutation of Npl3,
the presence of the budding yeast homolog of mammalian
PRMT1, Hmt1, is required for cell viability [60]. Hrp1 is the
subunitofcleavagefactorIthatisresponsibleforthecleavage
and polyadenylation of pre-mRNA 3 -ends [61]. Nab2 is
necessary for eﬃcient nuclear export of bulk mRNAs [62].
A detailedmutagenesisstudy on methylated arginines within
Npl3 showed that methylation is important for its nuclear
export, and thatthe methylation state ofNpl3islinkedto the
export of Hrp1 [63, 64]. Substitution mutations that change
methylated arginines within Hrp1tolysinesarenotsuﬃcient
to block its nuclear export, further supporting the notion
that methylated Npl3 is required for the export of Hrp1,
possibly as a part of the mature mRNP complex [64]. Npl3
is also phosphorylated, and this modiﬁcation controls its
nuclearimportandiscounteredbyargininemethylation [57,
65]. This example underscores the possibility that a protein’s
function can be regulated combinatorially by multiple post-
translational modiﬁcations. In sum, the consequences of
arginine methylation are generally changes in the subcellular
localization of hnRNPs, but with exceptions, such as for the
arginine methylation of mammalian hnRNP A1and L and of
the budding yeast protein Hrb1 [56].
A number of studies have shown that arginine methyla-
tion of an hnRNP compromises its ability to interact with
nucleic acids. For example, arginine methylation of hnRNP
A1 reduced its ability to bind to nonspeciﬁc single-stranded
nucleic acids [66]. Arginine methylation of Sam68 and its
homologues SLM-1 and SLM-2 (Sam68-like mammalian
proteins) impairs their ability to bind to poly(U) RNA [67],
and arginine methylation of Aly/REF leads to a decrease
in its association with mRNA in vivo [68]. However, there
are examples where arginine methylation does not aﬀect
the association of hnRNP with RNA [69–71]. For example,
Hrp1 is arginine methylated only when it is not bound to
RNA, as prior Hrp1 binding to RNA with a single UAUAUA
elementblocksHmt1-mediated methylation[71].Thus, how
arginine methylation modulates the binding capacity of
an hnRNP for nucleic acids appears to be inﬂuenced by
substrate rather than being a general phenomenon.
4.Arginine MethylationofSRProteins
The SR proteins, which are highly conserved at both the
functional and structural levels, are non-snRNP splicing4 Molecular Biology International
factors that have been proposed to play a role in the
early stages of spliceosome assembly (such as during the
recruitment of U1 snRNP and U2AF to the 5  and 3  ss),
and to facilitate formation of the U4/U6.U5 tri-snRNP
complex during the later steps of splicing (reviewed in [6]).
In addition, the SR proteins have been demonstrated to
aﬀect each step of post-transcriptional regulation (reviewed
in [72]). The SR proteins have a modular domain structure,
consisting of one or two RNA-recognition domains (RRM)
and a C-terminal rich in arginine/serine residues (RS-rich
domain). The RRM domain binds RNA, whereas the RS-
rich domainmodulatesbothinteractions with otherproteins
and interactions with pre-mRNA sequences. Currently, two
SR proteins have been identiﬁed that contain methylated
arginines: SFRS9/SRp30c[73]a n dS F 2 / A S F[ 74].
The human SFRS9/SRp30c has been implicated in splic-
ing control, based on the observation that interaction of
SFRS9/SRp30c with Tra2α, another SR-like protein, pro-
motes splicing of the gonadotropin-releasing hormone pre-
mRNA [75]. SFRS9/SRp30c attenuates the repressive eﬀect
of a downstream U1 snRNP binding site by stimulating the
splicing event to a downstream 5 -ss [76]. In human HEK-
293 cells, EGFP-tagged SFRS9/SRp30c accumulates in the
nucleoli upon treatment with AdOx, and has suggested that
SFRS9/SRp30c may play a role in maturation of snRNAs,
as these small RNAs transit through the nucleoli before
reaching the nuclear speckles [73].
SF2/ASF is a shuttling, broad-speciﬁcity splicing regu-
lator with additional roles in NMD [77], mRNA export
[78], and the regulation of translation [79]. Previous studies
have demonstrated that the phosphorylation of SF2/ASF
controls its subcellular localization [80]. In a recent report,
theKrainergroupshowedthatmethylationofthreearginines
located in the linkerregion of SF2/ASFregulates its subcellu-
lar localization, as an SF2/ASF mutant carrying substitution
mutations that convert all three arginines into alanines
displayedincreased cytoplasmicaccumulation[74].Whether
arginine methylation of SF2/ASF aﬀects its phosphorylation,
or vice versa, has not been determined. In these speciﬁc
triple-alanine mutants, in vitro and in vivo splicing were
compromised, and enhancement of NMD was no longer ob-
served [74]. The splicing defects observed are attributed to
the change in the subcellular levels of SF2/ASF, as restoring
the levels of the triple-alanine mutant in the nucleus to the
wild-type level rescued the splicing defects, consistent with
the previous observation that SF2/ASFregulates splicing in a
concentration-dependent manner [74, 81]. However, the
SF2/ASF triple-alanine mutant was not able to enhance




It is well established that the coupling of transcription with
mRNA processing is critical for mRNP biogenesis (reviewed
in [82]). Notably, whereas some of the factors are exclusive
for one process or the other, others such as mammalian
CA150 participate in both [83]. CA150 is methylated by
both PRMT4/CARM1 and PRMT5, and its methylation by
PRMT4/CARM1 promotes its interaction with the Tudor
domain of SMN [42, 84]. It is thought that methylation
of CA150 by PRMT4/CARM1 promotes exon skipping in
a methyltransferase enzyme-dependent manner [42]. Addi-
tionally, PRMT4/CARM1 methylates three splicing factors,
SmB, U1-C,and SAP49 [42]. In a separate study, the associa-
tion of U1-C with an isoform of PRMT4/CARM1 was found
to aﬀect 5 -ss selection during pre-mRNA splicing, albeit
in a nonenzymatic-dependent manner [85]. A recent study
showed that PRMT4/CARM1is automethylated, and regula-
tion of alternative splicing is impaired in PRMT4/CARM1
automethylation-defective mutants [86]. Thus, it appears
that PRMT4/CARM1 is capable of regulating pre-mRNA
splicing through more than one mechanism.
In vivo studies of spliceosome recruitment to actively
transcribed geneshavedelineatedthe orderofassembly, with
the U1 snRNP being the ﬁrst component recruited to a
newly formed 5  ss on the transcript, followed by the U2
and U5 snRNPs (reviewed in [87]). In mammalian cells,
the U1 snRNP is composed of U1-A, U1-C, and U1-70K
proteins (reviewed in [88]). Proteomic and immunological
analyses have demonstrated that U1-70K contains dimethy-
lated arginines [15, 89]. However, the PRMT responsible for
this modiﬁcation remains to be determined. In S. cerevisiae,
the U1-70K homolog Snp1 interacts with Hmt1 by two-
hybrid analysis and is an in vitro substrate of Hmt1 [89,
90]. ChIP-chip studies have shown that the loss of either
Hmt1 or its catalytic activity aﬀects the cotranscriptional
recruitment of a number of pre-mRNA splicing factors to
intron-containing genes [89]. The mechanistic explanation
for this observation is that loss of Hmt1’s catalytic activity
strengthens the protein-protein interaction between Snp1
and Npl3 [89]. In mammalian cells, the exon junction
complex(EJC)ispositionedonsplicedmRNAinasequence-
independentmannerduringthepre-mRNAsplicingreaction
[91]. Deposition of the EJC is also implicated in a number
of postsplicing events such as mRNA export, NMD, and
the control of translation (reviewed in [7, 92]). The EJC
component Y14 can be methylated by PRMT1 in vitro [93].
Like Npl3, Y14 is phosphorylated, and this phosphorylation
is antagonistic to its methylation [93]. A recent study
by the Tarn group indicated that Y14 interacts with the
cytoplasmicPRMT5-containingmethylosometopromoteits
methylation of the Sm protein [94].
6.Mechanisms by which Arginine Methylation
ModulatesmRNP Dynamics
Since the assembly of mRNPs during transcription is a
rapid and ordered process, each of the factors recruited has
the potential to inﬂuence downstream events depending on
where and when thefactoracts. Therefore, post-translational
modiﬁcation of mRNP components may provide the molec-
ular switch needed to allow mRNP components to act
dynamically, in concert with each other and in a timely
manner. Given the uniqueness of each mRNP complex,Molecular Biology International 5
large-scale genomic methods have provided the holistic view
of how arginine methylation impacts the in vivo recruit-
ment of mRNP components to their targets during mRNP
biogenesis. In yeast cells lacking Hmt1, the pattern of co-
transcriptional recruitment of Npl3 and the transcriptional
elongation factor Tho2 is similar to that in wild-type
cells [95]. However, the recruitment of downstream mRNP
components such as Hrp1, Nab2, and Yra1 diﬀers to various
degrees[95].Biochemical analysis indicates thatmethylation
islikelytoprovidethe“oﬀ”switchneededforNpl3andTho2
to interact with one another, and that failed disengagement
of these two factors is likely the reason for the observed
change in the subsequent mRNP dynamics [95]. In these
cells, binding between Npl3 and Snp1 is also aﬀected [89].
However, in this case, the loss of methylation results in their
failure to dissociate, which likely explains the compromised
co-transcriptional recruitment of U2 and U4/5/6-trisnRNPs
intheHmt1mutants[89].Inadditiontocontrollingprotein-
protein interactions between mRNP components, arginine
methylation modulates the ability of certain RNA-binding
proteins to target their nucleic acid substrates, as this
modiﬁcation increases hydrophobicity without changing the
positive charge ofthe arginine [96].Inaddition, asubstantial
loss of hydrogen bonding from methylation can also alter
the binding aﬃnity of the protein [97]. For many of the
hnRNPs, methylated arginines have been found in regions
with a known RNA-binding motif. Indeed, inhibition of
methylation at the arginine-glycine rich region of the fragile
X mental retardation protein (FMRP) reduces its ability to
bind its target mRNA [98]. Such reduced binding, however,
issometimes thenormal outcome.Forexample, methylation
of the mammalian mRNA export factor REF/ALY reduces
its RNA-binding capacity to ensure that the message can be
eﬃciently displaced by a second mRNA export factor known
as TAP [68].
Given the importance of coupling between transcrip-
tion and RNA processing events in the context of mRNP
biogenesis, it would not be surprising to ﬁnd that arginine
methylation of components exerts an eﬀect (possibly via
a feedback loop) on either the transcription or RNA-
processing machinery to preserve proper mRNP dynamics.
As previously mentioned, arginine methylation of CA150
inﬂuences the coupling of transcription and pre-mRNA
splicing [42].Inaddition, methylation ofhnRNPK enhances
the transcriptional activity of tumor suppressor p53 [99].
With regard to the reverse direction, studies in S. cerevisiae
have shown that changes in transcriptional elongation play a
role inHmt1-dependentrecruitment ofmRNAexport factor
Npl3 [100]. Recent studies have also connected chromatin
modiﬁcation to the regulation of alternative splicing [101]
and, since multiple PRMTs modify histones, histone modi-
ﬁcation is one potential area in which arginine methylation
could impact RNA processing events.
Itcan beinferred thata change inthe cellularlocalization
of proteins such as hnRNPs and SR proteins would lead
to defects in RNA traﬃcking since the majority of these
proteins are bound to mRNAs. Indeed, in cells treated with a
methyltransferase inhibitor, Sam68 fails to export unspliced
HIV viral RNAs [54]. The hnRNP A2 is implicated in
intracellular transport of the myelin basic protein (MBP)
mRNA. In cells treated with AdOx, cytoplasmic granules
containing hnRNP A2 are changed and this change cor-
relates with the presence of MBP mRNA granules close
to the nucleus [53]. A similar mode of regulation has
been implicated in regulation of the Ewing sarcoma RNA-
binding protein EWS [102], the Xenopus cold-inducible
RNA-binding protein CIRP2 [103], and RNA helicase A
[104, 105] .H o w e v e r ,i nt h ec a s eo fR N Ah e l i c a s eA ,a r g i n i n e
methylation modulates nuclear import as opposed to the
nuclearexportasinthecaseofmosthnRNPsandSRproteins
[106].
As transcription terminates, arginine methylation of the
remaining bound processing proteins modulates subsequent
steps, promoting further maturation and stability for trans-
lation in the cytoplasm. For example, in mammalian cells
a subunit of the mammalian pre-mRNA cleavage factor I
(CF Im68) can be methylated by both PRMT1 and PRMT5
in vitro [107]. However, the functional signiﬁcance of this
modiﬁcationonCFIm68functionremainstobeinvestigated.
Arginine methylation has also been identiﬁed in poly(A)-
binding protein family members, including PABP1 [12]a n d
PABP2 [108]. Poly(A)-binding proteins are involved in the
synthesis of poly(A) tails (reviewed in [109]). PABPN1,
the mammalian nuclear poly(A)-binding protein, can be
methylated by PRMT1, −3, and −6[ 110]. Unlike PABPN1,
the PABPN1 homolog in the ﬁssion yeast Schizosaccha-
romyces pombe (termed Pab2) is methylated only by the
PRMT1 homolog, Rmt1 [111]. Loss of arginine methylation
results in increased Pab2 self-association or aggregation
[111]. This phenotype, however, is not observed with the
mammalian PABPN1 [110] The mammalian Hu proteins
belong toa family ofhighly conservedRNA-bindingproteins
that help stabilize mRNAs prior to translation (reviewed
in [112]). HuR and HuD, two members of this family, are
in vitro substrates of PRMT4/CARM1 [113, 114]. Arginine
methylation of these two proteins regulates their binding to
mRNA, but in the opposite manner: methylation of HuR
further stabilizes the binding to the SIRT1 mRNA, whereas
methylation of HuD reduces its association with the p21
mRNA [115, 116].
7.ConcludingRemarksandFuturePerspectives
Understanding how arginine methylation modulates mRNP
dynamics has provided important insights into how post-
translational modiﬁcations impact mRNP biogenesis. Nev-
ertheless, the available data on the functional consequences
of this common modiﬁcation for mRNP dynamics remain
largely descriptive. From our current understanding, a
number of themes are beginning to emerge (Figure 1): (1)
arginine methylation leads to a change in the subcellular
concentration of an mRNP component, thereby controlling
its function. This type of regulatory mechanism is well
demonstrated for SF2/ASF,although its relevance to hnRNP-
mediated promotion of mRNP biogenesis remains unclear.
(2) Arginine methylation leads to a change in the capacity of























Figure 1: The eﬀects of protein arginine methylation on mRNP dynamics. Arginine methylation aﬀects the assembly of U-snRNPs,
components that constitute the spliceosome. The subcellular localization of both SR and hnRNP proteins are modulated by arginine
methylation. Loss of arginine methylation also results in co-transcriptional recruitment changes during mRNP biogenesis.
A perturbation of this type would lead to a perturbation
in the intricate number of functional connections with
various RNAprocessing factors, as well as the transcriptional
machinery, thereby allowing a diﬀerent set of proteins to be
recruited to a nascent transcript and altering the fate of the
mRNP. This mechanism enables arginine methylation to sig-
nal transition from one stageof mRNP biogenesis to thenext
at multiple interfaces, for example, between transcriptional
and RNA processing machineries (as in the case of CA150);
amongdistinctRNAprocessingmachineries (asinthecaseof
theinteractionbetweenNpl3andSnp1);amongcomponents
within large, macromolecular machineries important for
mRNP biogenesis (as for U-snRNP assembly). (3) Arginine
methylation promotes combinatorially, in conjunction with
other post-translational modiﬁcations. An example is the
phosphorylation and arginine methylation of Npl3, which
control either nuclear import or export. Additionally, com-
binatorial regulation with other post-translational modiﬁca-
tions such as ubiquitinationmay serve as a way to reverse the
eﬀectsofmethylation.Atthispoint,knowledgeofotherpost-
translational modiﬁcations on mRNP componentsis needed
to assess this possibility.
Recentadvancesin proteomicandimmunologicreagents
speciﬁc for dimethylarginines have contributed to the rapid
detection of this post-translational modiﬁcation in many
of the proteins that play a role in mRNP biogenesis.
However, identifying which PRMT(s) are responsible for
these modiﬁcations remains a challenge. This task is not
trivial, as the potential for a substrate to be methylated by
multiple PRMTs will increase the amount of work that will
be required to properly deﬁne the speciﬁc PRMT(s) for
each modiﬁcation. This scenario is exempliﬁed by the mam-
malian PABPN1, which is a substrate for multiple PRMTs
[110]. Studies in yeast have shown that methylarginines
serve as a molecular switch signaling the dissociation of
diﬀerent mRNP components during the progression of
mRNP biogenesis. One should also consider the possibility
of synergistic regulation between modiﬁed histones and
RNA processing proteins, given the emerging link between
a speciﬁc histone modiﬁcation and its ability to modulate
alternativesplicingevents[101].Indeed,anumberofPRMTs
that modify mRNP components have been shown to modify
histones [117, 118]
In conclusion, delineating the molecular mechanisms
underlying how arginine methylation inﬂuences diﬀerent
steps during mRNP biogenesis would provide signiﬁcant
insight intohow this modiﬁcation shapes the mRNPdynam-
ics. Given the prevalence of arginine methylation in factors
that participate at multiple stages of mRNP biogenesis, this
modiﬁcation is likely to contribute to the uniqueness of an
“mRNP code” that exists for each transcript in a given cell
type, by promoting speciﬁc molecular recognition events
responsible for the multitude of functional connections.
This “code” is dynamic, reﬂecting the changes that occur as
the primary transcript undergoes various processing steps.
Future studies employing high-throughput proteomics and
genomics technologies are expected to aid in elucidating the
impact of this modiﬁcation on mRNP dynamics.Molecular Biology International 7
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